| Withdrawn | Lung Cancer Screening CT for Firefighters NCT06836414 | University of California, San Francisco | N/A |
| Not Yet Recruiting | Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease NCT07473700 | Tectonic Operating Company, Inc. | Phase 2 |
| Recruiting | Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease NCT07372989 | Maule Stem Cell Research Institute, Inc. | Phase 1 |
| Recruiting | Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Stud NCT05819385 | Boehringer Ingelheim | — |
| Recruiting | H01 in Adults With Interstitial Lung Disease (The SOLIS Study) NCT06325696 | National Institute of Environmental Health Sciences (NIEHS) | Phase 2 |
| Recruiting | A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Conne NCT06572384 | GlaxoSmithKline | Phase 3 |
| Recruiting | A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease NCT06122233 | University of Sydney | N/A |
| Completed | Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases NCT06385301 | University of Zurich | N/A |
| Active Not Recruiting | Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD NCT05867914 | Third Pole Therapeutics, Inc. | N/A |
| Completed | Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Facto NCT05855109 | Boehringer Ingelheim | — |
| Recruiting | Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pul NCT05866198 | University of South Florida | N/A |
| Recruiting | Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases NCT06440746 | R-Pharm International, LLC | Phase 2 / Phase 3 |
| Completed | Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease NCT05957198 | Boehringer Ingelheim | — |
| Recruiting | NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases NCT05722340 | University Hospital, Montpellier | N/A |
| Completed | Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Trea NCT05875532 | Boehringer Ingelheim | — |
| Recruiting | Cough Capture as a Portal Into the Lung NCT05854563 | Albert Einstein College of Medicine | — |
| Completed | Muscles Oxygenation During Exercise in Fibrosing Interstitial Lung Diseases NCT05855447 | Saglik Bilimleri Universitesi | — |
| Completed | INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstiti NCT05151640 | Boehringer Ingelheim | — |
| Active Not Recruiting | Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connectiv NCT05503030 | Boehringer Ingelheim | — |
| Active Not Recruiting | A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease NCT05492994 | Boehringer Ingelheim | N/A |
| Completed | A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitia NCT05321082 | Boehringer Ingelheim | Phase 3 |
| Completed | Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease NCT05719233 | Assiut University | — |
| Completed | Using Thoracic Ultrasound to Detect Interstitial Lung Disease in Patients With Rheumatoid Arthritis NCT05396469 | Torkell Ellingsen | — |
| Completed | Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID NCT06383819 | NPO Petrovax | Phase 3 |
| Completed | A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease NCT05285982 | Boehringer Ingelheim | Phase 3 |
| Completed | A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis NCT05065190 | Boehringer Ingelheim | Phase 3 |
| Completed | BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease NCT04930666 | Columbia University | — |
| Terminated | Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases NCT04119115 | Corewell Health East | — |
| Unknown | Functional Exercise Tests in Patients With Systemic Sclerosis NCT04650659 | University of Aarhus | — |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial NCT04283994 | University of Washington | N/A |
| Completed | INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial NCT04702893 | Boehringer Ingelheim | — |
| Recruiting | Database for Interstitial Lung Disease NCT04707781 | Medical University of Graz | — |
| Completed | Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest NCT04170062 | Johns Hopkins University | N/A |
| Completed | Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressiv NCT04559581 | Boehringer Ingelheim | — |
| Completed | Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound NCT04195789 | Hospices Civils de Lyon | — |
| Unknown | Capnography Monitoring in Ventilated Children NCT04354220 | Vincenzo Cannizzaro | — |
| Active Not Recruiting | Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial NCT04325217 | Boehringer Ingelheim | — |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) NCT04281784 | University of Washington | N/A |
| Recruiting | A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC NCT04807114 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adoles NCT04093024 | Boehringer Ingelheim | Phase 3 |
| Unknown | Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients NCT04159129 | Schön Klinik Berchtesgadener Land | — |
| Completed | A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Int NCT03820726 | Boehringer Ingelheim | Phase 3 |
| Unknown | Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017 NCT03858842 | Hospices Civils de Lyon | — |
| Unknown | Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD). NCT04100226 | Cairo University | N/A |
| Unknown | Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exerci NCT03718780 | Centre Hospitalier Metropole Savoie | N/A |
| Completed | High Flow in Interstitial Lung Disease NCT03816722 | Aalborg University Hospital | N/A |
| Completed | Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced NCT04630743 | University of Cologne | N/A |
| Active Not Recruiting | BPF Genetics of ILD Study NCT03747627 | University of Dundee | — |
| Unknown | Research of Burden of Interstititial Lung Diseases in Turkey NCT03995654 | Karadeniz Technical University | — |
| Recruiting | Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis NCT03561818 | Istanbul Medipol University Hospital | N/A |
| Unknown | Interstitial Lung Disease (ILD). Diagnostic Yield of Surgical Lung Biopsy Versus Cryobiopsy in the Same Surgic NCT03596528 | Hospital Clinic of Barcelona | N/A |
| Terminated | Mapping Sound Propagation Through the Human Lung for Better Diagnosis NCT03043898 | Maximilian Nussbaumer | — |
| Completed | A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lun NCT03313180 | Boehringer Ingelheim | Phase 3 |
| Completed | Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease NCT03136120 | GlaxoSmithKline | — |
| Terminated | A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis NCT03142191 | Celgene | Phase 2 |
| Completed | A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease NCT03099187 | Hoffmann-La Roche | Phase 2 |
| Completed | Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) NCT02999178 | Boehringer Ingelheim | Phase 3 |
| Completed | Hepatitis C Virus(HCV) Heart and Lung Study NCT02858180 | Duke University | Phase 4 |
| Unknown | Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients W NCT02705144 | Sheba Medical Center | — |
| Completed | Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis NCT02370693 | Northwestern University | Phase 2 |
| Completed | Computed Tomography Assessment of Regional Ventilation (CURVE) NCT02879773 | Heart of England NHS Trust | — |
| Completed | The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease NCT02501668 | Keimyung University Dongsan Medical Center | — |
| Withdrawn | Identification of Novel Markers of Human Lung Disease NCT02369575 | Ohio State University | — |
| Unknown | Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study NCT02377739 | Schön Klinik Berchtesgadener Land | N/A |
| Completed | Idiopathic Pulmonary Fibrosis and Serum Bank NCT04016168 | Rennes University Hospital | — |
| Completed | Rituximab in Interstitial Pneumonitis NCT02251964 | Human Adams | Phase 2 / Phase 3 |
| Unknown | MSC for Treatment of Interstitial Lung Disease After Allo-HSCT NCT02543073 | Nanfang Hospital, Southern Medical University | Phase 1 / Phase 2 |
| Completed | Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients NCT02125916 | University of Aarhus | N/A |
| Completed | Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Mult NCT02464592 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | N/A |
| Recruiting | European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank NCT02852928 | Matthias Griese | — |
| Completed | A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma NCT01553981 | Sanjay Gandhi Postgraduate Institute of Medical Sciences | Phase 3 |
| Terminated | Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotrans NCT01432080 | Maisonneuve-Rosemont Hospital | Phase 2 |
| Completed | Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications NCT01374542 | Singapore General Hospital | — |
| Terminated | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF NCT01203943 | Celgene | Phase 2 |
| Unknown | Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection NCT00841750 | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | Phase 3 |
| Recruiting | Dorothy P. and Richard P. Simmons Center for ILD Research Registry NCT00258583 | University of Pittsburgh | — |
| Completed | Epidemiology of Surfactant Protein-B Deficiency NCT00014859 | Washington University School of Medicine | — |
| Completed | Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis NCT01442779 | Texas Tech University Health Sciences Center | Phase 2 |
| Completed | Linkage Study in Familial Pulmonary Fibrosis NCT00016627 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Terminated | Idiopathic Pulmonary Fibrosis: a Case-control Study NCT00005295 | University of New Mexico | — |
| Terminated | Epidemiology of Interstitial Lung Disease NCT00005290 | University of New Mexico | — |
| Completed | Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases NCT00005317 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| No Longer Available | An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs W NCT04739150 | Boehringer Ingelheim | — |
| Approved For Marketing | An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatmen NCT03843892 | Boehringer Ingelheim | — |
| Completed | Popcorn Lung: the Discovery of a New Disease NCT00027235 | National Center for Research Resources (NCRR) | — |